$MMM

JPMorgan Adjusts Price Target on 3M to $185 From $205

JPMorgan reduced its price target for 3M (MMM) from $205 to $185. Separately, Deutsche Bank adjusted its target to $194 from $192, maintaining a Hold rating. 3M's stock is currently at $163.58, up 0.34% year-to-date.

Original reporting
Published Oct 9, 2026, 11:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 11:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$MMM
Bearish
high confidence
Mentioned
$MMM
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$MMMBearishMed
01

Why it matters

The downgrade could trigger short-term selling and may influence other analysts' views.

02

Market read

Analyst target cut is a modest but actionable piece of news for traders holding or considering MMM.

03

What to watch

Potential upside from upcoming product launches or cost‑cutting initiatives not reflected in the target.

Relevance 7/10Novelty 7/10Timing: pre-market today

Background

JPMorgan's target adjustment follows its internal composite rating methodology, weighing valuation, EPS revisions, and visibility.

Company-level read

Ticker impact

$MMMBearishHigh confidence
Context

JPMorgan lowered its price target for 3M to $185 from $205, indicating a negative outlook for the stock.

Expected impact

likely downside pressure as investors price in the lower target.

Evidence & confidence

Target reductions typically lead to short-term sell pressure, especially when the cut is sizable (≈10%).

Market effects

May signal broader concerns for industrial conglomerates and the diversified industrial sector.

Primarily U.S. market impact; limited regional effect.

Low global relevance beyond investors tracking 3M.

Counterpoint

Some investors may view the cut as an overreaction and see buying opportunity at lower valuations.

Key entities

  • 3M

    Diversified industrial conglomerate (ticker MMM).

  • JPMorgan

    Investment bank providing the price target revision.

Related articles

$MMMMed

What Was Behind Bernstein’s 3M Upgrade, And Why It Isn’t a Buy?

Bernstein upgraded 3M (MMM) from Underperform to Market Perform, raising its price target to $171. Analyst Varun Govindaraj cited improved R&D strategy, AI-driven recovery, and lower PFAS legal risk. However, Bernstein sees limited upside due to recent stock gains and ongoing legal uncertainties. 3M's forward P/E is 21.92x, and its debt stands at $13.16 billion.

$GENIMed

Genius, CF, 3M, Nike, Synopsys Trending With Analysts

Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.

$MMMMed

3M’s CEO Says the Turnaround Is Ahead of Schedule, But PFAS Litigation Keeps Resurfacing

3M (NYSE:MMM) CEO William Brown reported that the company's operational turnaround is ahead of schedule, with improved margins, delivery performance, and new product launches. However, ongoing PFAS litigation, including a recent class action and a lawsuit by the Australian government, presents continued legal risks. 3M expects 20% of sales from new products by 2027 and is tracking above a 25% operating margin by that year.

$MMMMedAI 8/10

3M, DuPont must face Connecticut firefighters’ lawsuit over ’forever chemicals’

A federal judge ruled that 3M, DuPont, Honeywell, and others must face a lawsuit from Connecticut firefighters over toxic 'forever chemicals' in protective gear. The plaintiffs allege the chemicals increased cancer risk. The judge found the unions had standing to seek damages. PFAS, including 3M's Scotchlite and DuPont's Kevlar, were named. The lawsuit began in June 2024.

$MMMMedAI 8/10

3M sells €1.5B of Euro notes across 2028, 2031 and 2034 maturities

3M sold €1.5B in euro-denominated notes with maturities in 2028, 2031, and 2034, priced at 3.500%, 3.900%, and 4.100% respectively. The proceeds will be used for general corporate purposes, including potential debt repayment. The notes were issued under existing indentures with BNY Mellon as trustee, according to the company.